Small study demonstrates smart pill bottles can improve adherence interventions for cancer patients
A smart pill bottle platform improved adherence and patient satisfaction among a small sample of multiple myeloma patients, according to a paper in the November 2019 issue of the Journal of Managed Care & Specialty Pharmacy.
Researchers reported that median medication adherence was higher among those provided the smart pill bottle intervention (100% versus 87%; p = .001), with the lowest adherence rate within the intervention arm at 92%.
In addition, in a post-study survey, 60 percent of intervention program participants rated the full smart pill bottle program very positively.
The annual cost of the smart pill bottle platform and a single pharmacist intervention came to $1,210 per patient, and when paired with the 13% adherence improvement it represents a $96 incremental cost-effectiveness ratio (ICER) per percentage adherence.
The researchers wrote “While the study population was small, we postulate that other disease states with oral medication therapy requiring tight dosing windows, complicated dosing regimens or those with low adherence rates may benefit from smart pill bottle and pharmacist-targeted intervention programs.”
Study finds smart pill bottles effective in tracking patient behavior when combined with other sources
Another study in the July 2020 issue of JAMIA Open examined the effectiveness in tracking adherence rates of oral anticoagulant medication adherence among 160 AF (atrial fibrillation) patients over 6 months. The researchers utilized multiple data sources: a smart pill bottle, which was used to track pill bottle openings, and e-prescribing software, which was used to track medication refills.
Both the e-prescribing software and the smart pill bottle reported high adherence rates in the sample of AF patients (90.0% and 88.8%, respectively).
The researchers wrote: “Overall, the tracking technologies worked relatively well to track patient medication behavior; however, they did not capture exceptions. Overall, our study suggests that triangulating data from different sources …is critical for gathering accurate data on medication adherence.” In addition they suggested that “more research into the daily integration of smart pill bottles in the routines of chronically ill patients is necessary.”
AllazoHealth’s artificial intelligence technology treats each patient as an individual by personalizing interventions. By harnessing the power of predictive analytics, we tailor the channel, message, and frequency used for each patient throughout intervention programs, achieving a significant improvement in clinical outcomes and making interventions more cost-effective.
Improving the Effectiveness of Adherence Interventions by
5.45xWe worked alongside Blue Cross Blue Shield of North Carolina and their call center vendor to launch one of our biggest programs, working to improve adherence rates across their population of 104,392 Medicare Advantage Part D (MAPD) patients. We found that AllazoHealth targeted interventions accounted for 5.45 times the uplift in adherence compared to traditionally targeted interventions.